ERSOT
LGND icon

Employees Retirement System of Texas’s Ligand Pharmaceuticals LGND Stock Holding History

Employees Retirement System of Texas’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,668
Closed -$649K – 543
2022
Q2 		$649K Hold
11,668
– – 0.01% 651
2022
Q1 		$819K Hold
11,668
– – 0.01% 669
2021
Q4 		$1.12M Hold
11,668
– – 0.01% 623
2021
Q3 		$1.01M Hold
11,668
– – 0.01% 659
2021
Q2 		$955K Hold
11,668
– – 0.01% 669
2021
Q1 		$1.11M Sell
11,668
-8,817
-43% -$833K 0.01% 658
2020
Q4 		$1.27M Hold
20,485
– – 0.02% 564
2020
Q3 		$1.22M Hold
20,485
– – 0.02% 608
2020
Q2 		$1.43M Hold
20,485
– – 0.02% 562
2020
Q1 		$929K Hold
20,485
– – 0.02% 596
2019
Q4 		$1.33M Hold
20,485
– – 0.02% 639
2019
Q3 		$1.27M Sell
20,485
-7,888
-28% -$495K 0.02% 652
2019
Q2 		$2.02M Sell
28,373
-12,824
-31% -$945K 0.03% 552
2019
Q1 		$3.23M Buy
41,197
+4,809
+13% +$364K 0.05% 439
2018
Q4 		$3.08M Buy
36,388
+3,206
+10% +$342K 0.05% 425
2018
Q3 		$5.68M Sell
33,182
-10,259
-24% -$1.55M 0.08% 303
2018
Q2 		$5.61M Sell
43,441
-9,618
-18% -$1.07M 0.08% 307
2018
Q1 		$5.47M Hold
53,059
– – 0.07% 328
2017
Q4 		$4.53M Buy
53,059
+19,236
+57% +$1.67M 0.06% 401
2017
Q3 		$2.87M Buy
33,823
+14,427
+74% +$1.14M 0.04% 533
2017
Q2 		$1.47M Sell
19,396
-4,649
-19% -$325K 0.02% 726
2017
Q1 		$1.59M Hold
24,045
– – 0.02% 709
2016
Q4 		$1.52M Buy
+24,045
New +$1.52M 0.02% 714

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Employees Retirement System of Texas's LGND Position: Q3 2022 in Review

Employees Retirement System of Texas sold out of Ligand Pharmaceuticals (LGND) in Q3 2022, closing a stake of 11,668 shares — an estimated $649K sold.

Employees Retirement System of Texas first reported a position in LGND in Q4 2016 and held it in 23 quarters. The position peaked at $5.68M in Q3 2018. 205 funds tracked by Wall St. Rank hold LGND as of Q3 2022.

  • Employees Retirement System of Texas reported no remaining Ligand Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Employees Retirement System of Texas sold 11,668 Ligand Pharmaceuticals shares in Q3 2022, an estimated $649K.
  • Employees Retirement System of Texas first reported a position in Ligand Pharmaceuticals in Q4 2016 and held it in 23 quarters.
  • Employees Retirement System of Texas's Ligand Pharmaceuticals position peaked at $5.68M in Q3 2018.
  • 205 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2022.

Based on Employees Retirement System of Texas's 13F filing for Q3 2022, filed 10 Nov 2022.